<DOC>
	<DOCNO>NCT01534195</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness modify Conjunctival Allergen Challenge ( CAC ) observe produce allergic inflammation reacts treatment proven ocular anti-inflammatory medication , Prednisolone , assess follow measure : - Ocular itch - Conjunctival redness</brief_summary>
	<brief_title>Evaluation Efficacy Topical Ophthalmic Steroids Modified Conjunctival Allergen Challenge ( CAC ) Model</brief_title>
	<detailed_description>Prospective , single center , randomize , double-masked , placebo control study . Subjects randomize one follow treatment arm dose four time per day ( QID ) 8 day Visits 4 5 . - Prednisolone phosphate - Tears Naturale II Ophthalmic Solution ( Placebo ) Duration : Approximately 19 day Controls : Artificial Tears ( Tears NaturaleÂ® II )</detailed_description>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>At least 18 year age &amp; either sex , race Willing able follow instruction Positive history ocular allergy Reproducible positive ocular allergic reaction induce conjunctival allergen challenge Have plan surgery trial period Female currently pregnant , plan pregnancy lactate Use disallow medication Have ocular infection , ocular condition could affect study parameter Have moderate severe dry eye Have use investigational drug device within 30 day start study Female currently pregnant , plan pregnancy lactate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>